CI
STML

Cambiar Investors’s Stemline Therapeutics, Inc. STML Stock Holding History

Cambiar Investors’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-183,102
Closed -$886K – 166
2020
Q1 		$886K Buy
+183,102
New +$1.19M 0.04% 139

Cambiar Investors's STML Position: Q2 2020 in Review

Cambiar Investors sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 183,102 shares — an estimated $886K sold.

Cambiar Investors first reported a position in STML in Q1 2020 and held it in 1 quarter. The position peaked at $886K in Q1 2020. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

  • Cambiar Investors reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Cambiar Investors sold 183,102 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $886K.
  • Cambiar Investors first reported a position in Stemline Therapeutics, Inc. in Q1 2020 and held it in 1 quarter.
  • Cambiar Investors's Stemline Therapeutics, Inc. position peaked at $886K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Cambiar Investors's 13F filing for Q2 2020, filed 3 Aug 2020.